Edition:
United Kingdom

Elis SA (ELIS.PA)

ELIS.PA on Paris Stock Exchange

15.53EUR
16 Aug 2019
Change (% chg)

€0.24 (+1.57%)
Prev Close
€15.29
Open
€15.30
Day's High
€15.60
Day's Low
€15.30
Volume
306,057
Avg. Vol
378,696
52-wk High
€20.48
52-wk Low
€12.97

Latest Key Developments (Source: Significant Developments)

Eurazeo Sells Its Entire Stake In Elis
Friday, 26 Jul 2019 

July 26 (Reuters) - EURAZEO SE ::SALE OF ITS ENTIRE STAKE IN ELIS.TOTAL SALES PROCEEDS EUR 212 MLN.SALE OF 5.67% OF ELIS SHARE CAPITAL AT PRICE OF EUR 16.9 PER SHARE.AS A RESULT OF ITS INVESTMENT, EURAZEO REALIZED CAPITAL GAINS OF ABOUT EUR 440 MLN AND MULTIPLE OF 1.9X ITS INITIAL INVESTMENT .  Full Article

Elis SA Secondary ABO: Bookrunner Says Transaction Pricing At EUR 16.90 Per Share
Thursday, 25 Jul 2019 

July 25 (Reuters) - Elis SA ::ELIS SA SECONDARY ABO : BOOKRUNNER SAYS TRANSACTION PRICING AT EUR 16.90 PER SHARE BOOKS WILL CLOSE AT 18.20UKT.  Full Article

Elis H1 Reported EBITDA Rises To 519.0 Million Euros
Wednesday, 24 Jul 2019 

July 24 (Reuters) - ELIS SA ::H1 REPORTED EBITDA EUR 519.0 MILLION VERSUS EUR 469.1 MILLION RESTATED YEAR AGO.H1 REVENUE OF EUR 1,603.7MN, +5.1% AT CONSTANT FX RATES.2019 OUTLOOK CONFIRMED.EXPECTS ORGANIC REVENUE GROWTH OF C. 3% AND AN EBITDA MARGIN BETWEEN 31.2% AND 31.6% IN 2019.  Full Article

Elis H1 Net Profit Rises To 61.3 Million Euros
Wednesday, 24 Jul 2019 

July 24 (Reuters) - ELIS SA ::H1 NET PROFIT EUR 61.3 MILLION VERSUS PROFIT EUR 3.1 MILLION RESTATED YEAR AGO.  Full Article

Elis Announces Divestment Of One UK Division Of Clinical Solutions
Monday, 8 Jul 2019 

July 8 (Reuters) - ELIS SA ::REG-ELIS ANNOUNCES THE DIVESTMENT OF ONE DIVISION OF CLINICAL SOLUTIONS IN THE UK.SIGNED AN AGREEMENT TO DIVEST OF 100% OF SINGLE USE (ROCIALLE) / MEDICAL CONSUMABLES (GUARDIAN)DIVISION OF CLINICAL SOLUTIONS IN UK.CLOSING OF TRANSACTION IS EXPECTED TO TAKE PLACE BY END OF Q3 2019.  Full Article

Elis Q1 Revenue Up At 776.7 Million Euros
Thursday, 2 May 2019 

May 2 (Reuters) - ELIS SA ::REG-ELIS - Q1 2019 REVENUE.FULL-YEAR 2019 OBJECTIVE OF C. +3% CONFIRMED.2019 OUTLOOK CONFIRMED.WITH ORGANIC REVENUE GROWTH OF +2.4% IN Q1, ELIS IS STARTING YEAR WITH GOOD MOMENTUM IN MOST OF ITS GEOGRAPHIES.Q1 REVENUE EUR 776.7 MILLION VERSUS EUR 744.7 MILLION YEAR AGO.  Full Article

Elis Confirms Conditional Redemption Of Senior Notes For 800 Million Euros
Thursday, 25 Apr 2019 

April 25 (Reuters) - ELIS SA ::ELIS CONFIRMS CONDITIONAL REDEMPTION OF €800MN OF SENIOR NOTES.  Full Article

Elis FY EBITDA Grows To 985.6 Million Euros
Thursday, 7 Mar 2019 

March 7 (Reuters) - ELIS SA ::FY REVENUE: €3,133.3MN (+42.8% OF WHICH +2.6% ORGANIC GROWTH AND +2.4% ORGANIC GROWTH ON A PRO FORMA BASIS).FY EBITDA: €985.6MN (31.5% OF REVENUE).FOR 2019 SEES ORGANIC GROWTH OF C. +3.0%.SEES CAPEX AT 20% OF REVENUE IN 2019.2019 OUTLOOK: ORGANIC GROWTH OF C. +3.0%.PROPOSAL OF A PAYMENT OF €0.37 PER SHARE, STABLE VERSUS LAST YEAR.2019 OUTLOOK: EXPECTED EBITDA MARGIN OF BETWEEN 31.2% AND 31.6% OF REVENUE (EXCLUDING IFRS 16).2019 OUTLOOK: CAPEX AT 20% OF REVENUE.IN 2018, FREE CASH-FLOW WAS €153.7MN, UP +€272.7MN COMPARED TO 2017.FY HEADLINE NET RESULT EUR 224.3 MILLION VERSUS EUR 159.7 MILLION (RESTATED) YEAR AGO.GROUP ADJUSTED NET FINANCIAL DEBT AS OF 31 DECEMBER 2018 WAS €3,378.4MN.  Full Article

Elis Closes Acquisition Of Carpeting Entremattor In Sweden
Friday, 1 Mar 2019 

March 1 (Reuters) - ELIS SA ::REG-ELIS CLOSES THE ACQUISITION OF CARPETING ENTRÉMATTOR IN SWEDEN.  Full Article

Elis Appoints Antoine Burel As Chairman Of Audit Committee
Thursday, 21 Feb 2019 

Feb 21 (Reuters) - ELIS SA ::REG-ELIS: CHANGE IN THE COMPOSITION OF THE SUPERVISORY BOARD.ANTOINE BUREL WAS APPOINTED CHAIRMAN OF AUDIT COMMITTEE.  Full Article

French and Benelux stocks-Factors to watch

July 25 Below are company-related news and stories from French and Benelux media which could have an impact on the region's markets or individual stocks.